• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于制备结合疫苗的细菌荚膜寡糖的大小测定。

Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines.

作者信息

Ravenscroft N, Averani G, Bartoloni A, Berti S, Bigio M, Carinci V, Costantino P, D'Ascenzi S, Giannozzi A, Norelli F, Pennatini C, Proietti D, Ceccarini C, Cescutti P

机构信息

Chiron Vaccines SpA, Siena, Italy.

出版信息

Vaccine. 1999 Jul 16;17(22):2802-16. doi: 10.1016/s0264-410x(99)00092-4.

DOI:10.1016/s0264-410x(99)00092-4
PMID:10438050
Abstract

We recently described the use of ion exchange chromatography for analysis and the industrial scale preparation of pools of oligosaccharides of intermediate chain length from polysaccharides of Haemophilus influenzae type b (Hib) and Neisseria meningitidis groups A and C. These negatively charged "sized" oligosaccharides are activated and conjugated to the carrier protein (CRM197) to prepare the corresponding glycoconjugate vaccines. Characterization and accurate determination of the degree of polymerization (DP) of the pool of oligosaccharides is essential for the consistent production of these conjugate vaccines. This paper describes the colorimetric assays used for determination of the average DP of the Hib and meningococcal oligosaccharides, and the qualification of these assays achieved by size characterization of the respective oligosaccharides by use of physicochemical methods, including liquid chromatography, mass spectrometry (ionspray) and NMR spectroscopy.

摘要

我们最近描述了使用离子交换色谱法分析和工业规模制备来自b型流感嗜血杆菌(Hib)以及A群和C群脑膜炎奈瑟菌多糖的中等链长寡糖库。这些带负电荷的“分级”寡糖被活化并与载体蛋白(CRM197)偶联,以制备相应的糖共轭疫苗。寡糖库聚合度(DP)的表征和准确测定对于这些共轭疫苗的稳定生产至关重要。本文描述了用于测定Hib和脑膜炎球菌寡糖平均DP的比色测定法,以及通过使用包括液相色谱、质谱(离子喷雾)和核磁共振光谱在内的物理化学方法对相应寡糖进行尺寸表征而实现的这些测定法的鉴定。

相似文献

1
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines.用于制备结合疫苗的细菌荚膜寡糖的大小测定。
Vaccine. 1999 Jul 16;17(22):2802-16. doi: 10.1016/s0264-410x(99)00092-4.
2
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135.用于制备抗Y群和W135群脑膜炎奈瑟菌结合疫苗的细菌荚膜寡糖的大小测定
Vaccine. 2005 Mar 14;23(16):1887-99. doi: 10.1016/j.vaccine.2004.10.021.
3
A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines.b型流感嗜血杆菌与C群脑膜炎球菌结合疫苗之间的物理化学相互作用研究
Afr Health Sci. 2007 Dec;7(4):190-6.
4
Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity.b型流感嗜血杆菌外膜蛋白复合物糖共轭疫苗通过与人 Toll 样受体 2(TLR2)结合诱导细胞因子产生,且最佳免疫原性需要 TLR2 的存在。
J Immunol. 2004 Feb 15;172(4):2431-8. doi: 10.4049/jimmunol.172.4.2431.
5
Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.两名C2缺陷姐妹对脑膜炎奈瑟菌和b型流感嗜血杆菌荚膜多糖的疫苗接种反应:替代途径介导的细菌杀伤作用及新型阻断性IgG的证据
J Clin Immunol. 2000 Mar;20(2):138-49. doi: 10.1023/a:1006638631581.
6
Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines.用于结合疫苗的细菌荚膜多糖的尺寸分级分离。
Vaccine. 1999 Mar 5;17(9-10):1251-63. doi: 10.1016/s0264-410x(98)00348-x.
7
Prophylaxis of bacterial meningitis.细菌性脑膜炎的预防
Infect Dis Clin North Am. 1999 Sep;13(3):685-710, viii. doi: 10.1016/s0891-5520(05)70101-x.
8
Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.B 型流感嗜血杆菌多糖疫苗或结合疫苗在老年人群中的安全性和免疫原性。
J Am Geriatr Soc. 2004 Nov;52(11):1883-7. doi: 10.1111/j.1532-5415.2004.52511.x.
9
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine.关于重组B群脑膜炎球菌孔蛋白作为新型b型流感嗜血杆菌结合疫苗载体的临床前研究。
Vaccine. 1998 Nov;16(19):1842-9. doi: 10.1016/s0264-410x(98)00174-1.
10
Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.载体蛋白免疫对b型流感嗜血杆菌结合疫苗抗体反应的影响。
Vaccine. 1993;11 Suppl 1:S46-51. doi: 10.1016/0264-410x(93)90160-y.

引用本文的文献

1
A Multidisciplinary Structural Approach to the Identification of the Type b Capsular Polysaccharide Protective Epitope.一种用于鉴定b型荚膜多糖保护性表位的多学科结构方法。
ACS Cent Sci. 2024 Feb 22;10(5):978-987. doi: 10.1021/acscentsci.3c01515. eCollection 2024 May 22.
2
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.探索影响传统和创新糖缀合物疫苗免疫反应的变量。
Front Mol Biosci. 2023 May 16;10:1201693. doi: 10.3389/fmolb.2023.1201693. eCollection 2023.
3
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.
聚糖链长度和连接类型对糖结合疫苗免疫原性的联合影响。
NPJ Vaccines. 2021 Dec 10;6(1):150. doi: 10.1038/s41541-021-00409-1.
4
Cross-reactivity of Haemophilus influenzae type a and b polysaccharides: molecular modeling and conjugate immunogenicity studies.甲型和乙型流感嗜血杆菌多糖的交叉反应性:分子建模和结合免疫原性研究。
Glycoconj J. 2021 Dec;38(6):735-746. doi: 10.1007/s10719-021-10020-0. Epub 2021 Sep 7.
5
Post-Glycosylation Modification of Sialic Acid and Its Role in Virus Pathogenesis.唾液酸的糖基化后修饰及其在病毒致病机制中的作用
Vaccines (Basel). 2019 Nov 1;7(4):171. doi: 10.3390/vaccines7040171.
6
Characterization of the Conjugation Pattern in Large Polysaccharide-Protein Conjugates by NMR Spectroscopy.通过 NMR 光谱法对大多糖-蛋白质缀合物的缀合模式进行表征。
Angew Chem Int Ed Engl. 2017 Nov 20;56(47):14997-15001. doi: 10.1002/anie.201709274. Epub 2017 Oct 19.
7
A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine.一种用于测定脑膜炎球菌多糖疫苗分子大小分布的高通量尺寸排阻色谱法。
Int J Anal Chem. 2016;2016:9404068. doi: 10.1155/2016/9404068. Epub 2016 Sep 5.
8
Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.破伤风类毒素结合细菌多糖疫苗中载体蛋白识别的结构相关性
Vaccine. 2015 Mar 10;33(11):1345-52. doi: 10.1016/j.vaccine.2015.01.046. Epub 2015 Jan 29.
9
Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production.A群脑膜炎奈瑟菌荚膜生物合成复合体组分的分子克隆与功能表征:迈向体外疫苗生产
J Biol Chem. 2014 Jul 11;289(28):19395-407. doi: 10.1074/jbc.M114.575142. Epub 2014 May 21.
10
Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.联合偶联疫苗:以N19多表位作为载体蛋白增强免疫原性。
Infect Immun. 2005 Sep;73(9):5835-41. doi: 10.1128/IAI.73.9.5835-5841.2005.